Predicting recurrence in patients with localised renal cell carcinoma after nephrectomy

被引：4

作者：

Lotan, Yair ^{[1
]}

Margulis, Vitaly ^{[1
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA

来源：

LANCET ONCOLOGY | 2019年 / 20卷 / 04期

关键词：

HIGH-RISK; ADJUVANT SUNITINIB;

D O I：

10.1016/S1470-2045(19)30024-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：473 / 475

页数：3

共 9 条

[1] ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma [J].

Brooks, Samira A. ;

Brannon, A. Rose ;

Parker, Joel S. ;

Fisher, Jennifer C. ;

Sen, Oishee ;

Kattan, Michael W. ;

Hakimi, A. Ari ;

Hsieh, James J. ;

Choueiri, Toni K. ;

Tamboli, Pheroze ;

Maranchie, Jodi K. ;

Hinds, Peter ;

Miller, C. Ryan ;

Nielsen, Matthew E. ;

Rathmell, W. Kimryn .

EUROPEAN UROLOGY, 2014, 66 (01) :77-84

[2] Adjuvant Treatment for High-Risk Clear Cell Renal Cancer Updated Results of a High-Risk Subset of the ASSURE Randomized Trial [J].

Haas, Naomi B. ;

Manola, Judith ;

Dutcher, Janice P. ;

Flaherty, Keith T. ;

Uzzo, Robert G. ;

Atkins, Michael B. ;

DiPaola, Robert S. ;

Choueiri, Toni K. .

JAMA ONCOLOGY, 2017, 3 (09) :1249-1252

[3] Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial [J].

Haas, Naomi B. ;

Manola, Judith ;

Uzzo, Robert G. ;

Flaherty, Keith T. ;

Wood, Christopher G. ;

Kane, Christopher ;

Jewett, Michael ;

Dutcher, Janice P. ;

Atkins, Michael B. ;

Pins, Michael ;

Wilding, George ;

Cella, David ;

Wagner, Lynne ;

Matin, Surena ;

Kuzel, Timothy M. ;

Sexton, Wade J. ;

Wong, Yu-Ning ;

Choueiri, Toni K. ;

Pili, Roberto ;

Puzanov, Igor ;

Kohli, Manish ;

Stadler, Walter ;

Carducci, Michael ;

Coomes, Robert ;

DiPaola, Robert S. .

LANCET, 2016, 387 (10032) :2008-2016

[4] Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions [J].

Lalani, Aly-Khan A. ;

McGregor, Bradley A. ;

Albiges, Laurence ;

Choueiri, Toni K. ;

Motzer, Robert ;

Powles, Thomas ;

Wood, Christopher ;

Bex, Axel .

EUROPEAN UROLOGY, 2019, 75 (01) :100-110

[5] Adjuvant therapy for advanced renal cell carcinoma [J].

Meissner, Matthew A. ;

McCormick, Barrett Z. ;

Karam, Jose A. ;

Wood, Christopher G. .

EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (07) :663-671

[6] Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results [J].

Motzer, Robert J. ;

Ravaud, Alain ;

Patard, Jean-Jacques ;

Pandha, Hardev S. ;

George, Daniel J. ;

Patel, Anup ;

Chang, Yen-Hwa ;

Escudier, Bernard ;

Donskov, Frede ;

Magheli, Ahmed ;

Carteni, Giacomo ;

Laguerre, Brigitte ;

Tomczak, Piotr ;

Breza, Jan ;

Gerletti, Paola ;

Lechuga, Mariajose ;

Lin, Xun ;

Casey, Michelle ;

Serfass, Lucile ;

Pantuck, Allan J. ;

Staehler, Michael .

EUROPEAN UROLOGY, 2018, 73 (01) :62-68

[7] A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies [J].

Rini, Brian ;

Goddard, Audrey ;

Knezevic, Dejan ;

Maddala, Tara ;

Zhou, Ming ;

Aydin, Hakan ;

Campbell, Steven ;

Elson, Paul ;

Koscielny, Serge ;

Lopatin, Margarita ;

Svedman, Christer ;

Martini, Jean-Francois ;

Williams, J. Andrew ;

Verkarre, Virginie ;

Radulescu, Camelia ;

Neuzillet, Yann ;

Hemmerle, Isabelle ;

Timsit, Marc Olivier ;

Tsiatis, Athanasios C. ;

Bonham, Michael ;

Lebret, Thierry ;

Mejean, Arnaud ;

Escudier, Bernard .

LANCET ONCOLOGY, 2015, 16 (06) :676-685

[8] Renal cell carcinoma [J].

Rini, Brian I. ;

Campbell, Steven C. ;

Escudier, Bernard .

LANCET, 2009, 373 (9669) :1119-1132

[9]

Wei JH, 2019, LANCET ONCOL, V20, P591, DOI [10.1016/S1470-2045(18)30932-x, 10.1016/S1470-2045(18)30932-X]

← 1 →